Neoleukin Therapeutics
Neoleukin Therapeutics:
Develops next-generation immunotherapies for cancer, inflammation and autoimmunity using de novo protein design technology. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to improve tolerability and activity by eliminating the alpha receptor binding interface. NL-201 is currently being evaluated in a Phase 1 clinical trial in patients with relapsed or refractory cancer and the company is expecting interim data in 2022. Cash $164.2M as of June 30, 2021; sufficiently capitalized to fund operations into 2023
Sector/Industry:
Healthcare/Drug Manufacturers
Characteristics:
Based in...
US - Pacific
Clinical Stage
Pre-Clinical Stage
Disease Space
Allergy, Autoimmune, Immuno-Oncology, Infectious Disease, Oncology
Listing
Public, USA
Market Cap
<100MM
Website:
Profiles:
Address:
1616 Eastlake Avenue E
Suit 360
Seattle, WA 98109
United States
Suit 360
Seattle, WA 98109
United States
More info:
My account:
Company Participants at Solebury Trout Hamptons CEO Roundtable 2021
- Jonathan G. Drachman, President/CEO/CFO
Top 10 Holders of Neoleukin Therapeutics, Inc
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 9.00 | 3,824,000 | 4.02 | Stakes | 5/12/22 |
| Redmile Group LLC | 8.16 | 3,465,435 | 3.64 | 13F | 3/31/22 |
| Pictet Asset Management SA | 6.06 | 2,574,315 | 2.70 | 13F | 3/31/22 |
| Millennium Management LLC | 5.02 | 2,132,586 | 2.24 | Stakes | 7/18/22 |
| BlackRock Fund Advisors | 3.65 | 1,551,576 | 1.63 | 13F | 3/31/22 |
| Candriam Belgium SA | 3.41 | 1,448,598 | 1.52 | Funds | 4/29/22 |
| Renaissance Technologies LLC | 2.99 | 1,268,969 | 1.33 | 13F | 3/31/22 |
| Vanguard Group, Inc. (Subfiler) | 2.92 | 1,240,585 | 1.30 | 13F | 3/31/22 |
| Point72 Asset Management LP (Old) | 2.88 | 1,225,000 | 1.29 | 13F | 3/31/22 |
| The Vanguard Group, Inc. | 2.72 | 1,155,071 | 1.21 | Funds | 6/30/22 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2022 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.